Just for a bit of light relief. Clinuvel have misspelled the name of the first author on the most relevant paper cited in this announcement( twice in 2 weeks!) Just more quality control. Rosenfeld wouldn’t have accepted this incompetence in his academic/clinical days, disappointing he’s running such a sloppy outfit now. I still find it hard to believe this lot have trouble running trials, dealing with regulators and payors. Their quality control is beyond reproach.
hope everyone enjoyed the little pump/dump
Ann: Afamelanotide Assists DNA Repair Response Following UVR, page-80
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.73 |
Change
0.120(0.88%) |
Mkt cap ! $687.3M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.90 | $13.54 | $835.5K | 61.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 312 | $13.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.76 | 226 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |